Trials / Unknown
UnknownNCT03447145
A New Drug Used for Advanced Cancer
Phase I Study of Tolerance and Pharmacokinetics of TQ-B3203
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
To identify the safety and tolerance of TQ-B3203.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TQ-B3203 | dose escalation, 2/4/6/10/14/18mg/m2 |
Timeline
- Start date
- 2017-12-26
- Primary completion
- 2018-12-26
- Completion
- 2018-12-26
- First posted
- 2018-02-27
- Last updated
- 2018-02-27
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03447145. Inclusion in this directory is not an endorsement.